During the 2016 election, much of the country was introduced to the concept of internet bots for the first time. Now, just a decade later, it feels like they’re everywhere.

It was made by a Carnegie Mellon roboticist in his 30s named Hans Moravec. This is what Moravec did: While trying to get his ...

A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

When Sydney Scotia, who pivoted from acting to running a business, started suffering from migraines, she knew something had ...

Could These 3 New-to-Market Quantum Computing Firms Threaten D-Wave? Horizon Quantum Computing Pte. (NASDAQ:HQ) reported a ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.87% at $2.89. This change lagged the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy ...

Recently, a technique called equality saturation adapted e-graphs for program optimization. Equality saturation can ...